You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Insulin Articles
Popular Insulin Articles
Highly Recommended Insulin Articles
Send a link to this page to your friends and colleagues.
If you use lispro (Humalog) insulin in your pump and are seeing dents in your skin at your infusion sites, a switch in insulin can stop the problem.
The situation, called lipoatrophy, happens when the fatty tissue under the skin disappears. Lipoatrophy, more common in the past, was believed to have been caused by reactions to insulins that are not as pure as today's human-origin compounds. However, at least three recent cases of lipoatrophy involving the use of Humalog in a pump has led doctors from the Yale University and West Virginia University schools of medicine to caution others to be on the lookout for the problem.
The doctors, writing in the "Letters" section of the January 2001 issue of Diabetes Care, observed two incidents of lipoatrophy and received correspondence from a colleague who observed one case.
Switching to human-based buffered Regular insulin in the form of Velosulin alleviated the problems with lipoatrophy.
Doctors say evidence points to Humalog—not the delivery system—as being the primary factor in causing lipoatrophy.
5 comments - Apr 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.